2019
DOI: 10.1007/s12031-019-01430-9
|View full text |Cite
|
Sign up to set email alerts
|

Digenic Variants as Possible Clinical Modifier of Primary Familial Brain Calcification Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…Calcification degree and scope could be revealed by CT scan in the clinic, and these brain lesions had nearly complete penetrance for those harboring causative mutations, whereas its variable expressivity among patients with PFBC suggests the detrimental or protective effects of other genetic modifiers. Moreover, environmental factors could also affect the severity of brain calcification (de Oliveira et al, 2013;Donzuso et al, 2019;Grangeon et al, 2019;Borges-Medeiros and de Oliveira, 2020). The multisystem abnormalities and extensive brain calcifications found only in Slc20a2-HO mice might be explained by the discrepancy in gene dosage sensitivity between mice and humans.…”
Section: Gene Dosage Effect and Sensitivity In Mice And Patients With Pfbcmentioning
confidence: 99%
“…Calcification degree and scope could be revealed by CT scan in the clinic, and these brain lesions had nearly complete penetrance for those harboring causative mutations, whereas its variable expressivity among patients with PFBC suggests the detrimental or protective effects of other genetic modifiers. Moreover, environmental factors could also affect the severity of brain calcification (de Oliveira et al, 2013;Donzuso et al, 2019;Grangeon et al, 2019;Borges-Medeiros and de Oliveira, 2020). The multisystem abnormalities and extensive brain calcifications found only in Slc20a2-HO mice might be explained by the discrepancy in gene dosage sensitivity between mice and humans.…”
Section: Gene Dosage Effect and Sensitivity In Mice And Patients With Pfbcmentioning
confidence: 99%
“…All PFBC patients with biallelic SLC20A2 variants showed more severe phenotypes than their family members with heterozygous variants, which indicated that the second mutation might promote the development of PFBC. Coincidentally, PFBC patients with variants in both a PFBC pathogenic gene (SLC20A2 or PDGFRB) and another PFBC-unrelated gene (THAP1, CHRNB2, CASR, SCN2A or MEA6) were described as presenting more complex phenotypes, supporting the notion that a variant of a second gene may promote a heterogeneous phenotype in PFBC patients (Baker et al, 2014;Borges-Medeiros & de Oliveira, 2020;DeMeo et al, 2018;Fjaer et al, 2015;Fujioka et al, 2015;Knowles et al, 2018). The SLC20A2 c.1787A>G (p.His596Arg) variant detected in our study has been reported to cause brain calcification without clinical manifestations due to PiT2 dysfunction, which probably results in the accumulation of Pi in affected brain regions (Guo et al, 2019).…”
Section: Discussionmentioning
confidence: 88%
“…In contrast, PDGFRB has the lowest clinical penetrance (46%) [ 3 ]. The clinical variability and reduced penetrance may be influenced by other yet unidentified genetic modifiers [ 28 ].…”
Section: Clinical Presentationsmentioning
confidence: 99%